We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 2,349

When Is A Timely IPR Petition Not Timely Enough?
  • Jones Day
  • USA
  • September 17 2018

A petition for inter partes review is timely if it is filed within one year of service of a complaint alleging infringement of the challenged patent


Pfizer Loses Out On Its Follow-On Petition Challenges to Genentech’s anti-HER2 Patents Because It Did Not Follow General Plastics Guidance
  • Rothwell, Figg, Ernst & Manbeck, PC
  • USA
  • September 11 2018

Recently, Pfizer was denied institution of two follow-on inter partes review (IPR) petitions, IPR Nos. 2018-00330 and 2018-00331 (“the 2018


Petitioners Be Mindful Of Decisions In Related IPRs
  • Jones Day
  • USA
  • September 3 2018

In a recent PTAB decision, Petitioners learned the importance of addressing decisions from related IPRs when making arguments before the PTAB. Apple


Hiring and firing internationally: tips for dealing with staff overseas
  • Taylor Wessing
  • United Kingdom, European Union
  • August 7 2018

Recruiting new staff overseas can be exciting, and perhaps slightly daunting. Whether your business is starting up, or expanding to a new foreign base


Federal Circuit Splits Hairs in Hair Removal Product Interference Proceeding
  • Marshall Gerstein & Borun LLP
  • USA
  • August 7 2018

In General Hospital Corp. v. Sienna Biopharmaceuticals, Inc., Case No. 2017-1012 (Fed. Cir. May 4, 2018), the Federal Circuit affirmed the PTAB’s


Strategic Budgeting Can Result in Early Resolution of False Claims Act Cases
  • Jones Day
  • USA
  • August 7 2018

The vast majority of FCA cases begin as qui tam cases filed by individual whistleblowers ("relators"). Qui tam cases are filed under seal to give the


Publication Need not be IndexedSearchable to be Prior Art
  • Ropes & Gray LLP
  • USA
  • July 31 2018

Last week, I pointed out that the Federal Circuit faulted the Patent Trial & Appeal Board (PTAB) for its narrow public accessibility analysis in


Printed Publications & The PTAB
  • Ropes & Gray LLP
  • USA
  • July 26 2018

Yesterday I highlighted a significant decision for Patent Trial & Appeal Board (PTAB) practitioners pertaining to Real-Party-In-Interest (RPI) and


CSA Reinforces Position that Securities Laws Apply to Cryptocurrency Offerings, Confirms Regulatory Scrutiny for Industry Participants
  • McMillan LLP
  • Canada
  • July 26 2018

Capital Markets Bulletin July 2018 CSA Reinforces Position that Securities Laws Apply to Cryptocurrency Offerings, Confirms Regulatory Scrutiny for


Time-rounding systems endorsed by California court despite net loss to named plaintiffs
  • Hunton Andrews Kurth LLP
  • USA
  • July 18 2018

In AHMC Healthcare, Inc. v. Superior Court of Los Angeles County, No. B285655 (June 25, 2018) (“AHMC Healthcare”), California’s Second District Court